SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-014908
Filing Date
2017-08-02
Accepted
2017-08-02 16:16:42
Documents
59
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q omed-10q_20170630.htm 10-Q 1530651
2 EX-31.1 omed-ex311_7.htm EX-31.1 16494
3 EX-31.2 omed-ex312_8.htm EX-31.2 16526
4 EX-32.1 omed-ex321_6.htm EX-32.1 8483
  Complete submission text file 0001564590-17-014908.txt   5484736

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT omed-20170630.xml EX-101.INS 1242984
6 XBRL TAXONOMY EXTENSION SCHEMA omed-20170630.xsd EX-101.SCH 40485
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE omed-20170630_cal.xml EX-101.CAL 31275
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omed-20170630_def.xml EX-101.DEF 147598
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE omed-20170630_lab.xml EX-101.LAB 281410
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omed-20170630_pre.xml EX-101.PRE 247529
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Filer) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35993 | Film No.: 171000111
SIC: 2834 Pharmaceutical Preparations